Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22479 | 24528352 | Nutr Hosp | [Hepatic steatosis as diabetes type 2 predictor]. | 2014 | Details |
| A22483 | 24522441 | Am J Clin Nutr | Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. | 2014 | Details |
| A22503 | 24512822 | J Hepatol | Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. | 2013 | Details |
| A22504 | 24512497 | J Clin Endocrinol Metab | Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. | 2014 | Details |
| A22508 | 24505484 | PLoS One | Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. | 2014 | Details |
| A22514 | 24499025 | BMC Genomics | The effect of dietary fat intake on hepatic gene expression in LG/J AND SM/J mice. | 2014 | Details |
| A22543 | 24475948 | Cardiovasc Diabetol | Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea? | 2014 | Details |
| A22558 | 24463897 | Arq Bras Cir Dig | Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity. | 2013 | Details |
| A22565 | 24460502 | Gynecol Endocrinol | Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. | 2014 | Details |
| A22572 | 24455970 | Ren Fail | Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients. | 2014 | Details |
| A22594 | 24434909 | Gerontology | Age-related consequences of childhood obesity. | 2014 | Details |
| A22607 | 24417951 | Best Pract Res Clin Endocrinol Metab | Adiponectin as a routine clinical biomarker. | 2013 | Details |
| A22612 | 24415281 | Obes Surg | Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation. | 2014 | Details |
| A22618 | 24404139 | PLoS One | Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. | 2014 | Details |
| A22624 | 24402015 | Arq Bras Endocrinol Metabol | Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease. | 2013 | Details |
| A22628 | 24397589 | Lipids Health Dis | Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. | 2014 | Details |
| A22645 | 24385405 | Adv Ther | Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A22650 | 24381873 | Indian J Endocrinol Metab | Imaging of non alcoholic fatty liver disease: A road less travelled. | 2013 | Details |
| A22653 | 24380887 | Biochem Pharmacol | Brain metabolic dysfunction at the core of Alzheimer's disease. | 2013 | Details |
| A22658 | 24378273 | Ann Hepatol | Effects of bile acid sequestration on hepatic steatosis in obese mice. | 2014 | Details |
| A22668 | 24374462 | Cochrane Database Syst Rev | Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2013 | Details |
| A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
| A22686 | 25951695 | Przegl Lek | [Determinants of nonalcoholic fatty liver disease in men and women with type 2 diabetes]. | 2014 | Details |
| A22691 | 25911908 | Eksp Klin Gastroenterol | [Adipokines and liver function in patients with nonalcoholic fatty liver disease, type 2 diabetes mellitus and its combination]. | 2014 | Details |
| A22692 | 25859286 | Clin Epigenetics | Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease. | 2014 | Details |
| A22709 | 24365733 | Korean J Gastroenterol | Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study. | 2013 | Details |
| A22712 | 24363521 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. | 2013 | Details |
| A22744 | 24336007 | Med Sci Monit | Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes. | 2013 | Details |
| A22747 | 24333862 | J Hepatol | A population-based study on the prevalence of NASH using scores validated against liver histology. | 2013 | Details |
| A22755 | 24327959 | Mol Metab | Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis. | 2013 | Details |
| A22759 | 24326426 | Am J Physiol Endocrinol Metab | Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. | 2013 | Details |
| A22762 | 24324835 | PLoS One | Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome. | 2013 | Details |
| A22772 | 24317388 | Blood Coagul Fibrinolysis | Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease. | 2014 | Details |
| A22773 | 24317120 | Nat Med | Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy. | 2013 | Details |
| A22786 | 24303796 | Clin Endocrinol (Oxf) | Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. | 2013 | Details |
| A22788 | 24303686 | Acta Gastroenterol Latinoam | [Relationship between dietary glycemic index and glycemic load and nonalcoholic fatty liver disease in elderly]. | 2013 | Details |
| A22790 | 24303090 | World J Hepatol | Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. | 2013 | Details |
| A22798 | 24297186 | Rev Endocr Metab Disord | Adiponectin signaling in the liver. | 2014 | Details |
| A22815 | 26182139 | Clin J Gastroenterol | A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy. | 2013 | Details |
| A22817 | 25755514 | J Clin Exp Hepatol | Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection. | 2013 | Details |
| A22819 | 24287794 | Endocrine | Non-alcoholic fatty liver disease: a diabetologist's perspective. | 2013 | Details |
| A22828 | 24277674 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes in obese children. | 2014 | Details |
| A22829 | 24277052 | J Gastroenterol | Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. | 2013 | Details |
| A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
| A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
| A22855 | 24251708 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: factors associated with its presence and onset. | 2013 | Details |
| A22857 | 24251706 | J Gastroenterol Hepatol | Diet and exercise in management of obesity and overweight. | 2013 | Details |
| A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
| A22859 | 24251697 | J Gastroenterol Hepatol | Role of the gut microbiota in human nutrition and metabolism. | 2013 | Details |
| A22864 | 24268118 | J Cardiovasc Comput Tomogr | Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
| A22867 | 24266914 | Med Clin North Am | Review of treatment options for nonalcoholic fatty liver disease. | 2013 | Details |
| A22871 | 24264040 | Int J Mol Sci | Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. | 2013 | Details |
| A22876 | 24260182 | PLoS One | The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. | 2013 | Details |
| A22879 | 24259612 | Ann Pharmacother | Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. | 2013 | Details |
| A22889 | 24250305 | Afr Health Sci | Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. | 2013 | Details |
| A22896 | 24235062 | World J Pediatr | Type 2 diabetes mellitus in pediatrics: a new challenge. | 2013 | Details |
| A22898 | 24226095 | J Biol Chem | Retinoic acid-related orphan receptor α regulates diurnal rhythm and fasting induction of sterol 12α-hydroxylase in bile acid synthesis. | 2013 | Details |
| A22900 | 24223115 | PLoS One | Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A22902 | 24222944 | World J Gastroenterol | Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. | 2013 | Details |
| A22918 | 24211299 | Gastroenterology | Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. | 2013 | Details |
| A22922 | 24206739 | Arab J Gastroenterol | Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22927 | 24205725 | Nihon Rinsho | [Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides]. | 2013 | Details |
| A22932 | 24196453 | Semin Immunopathol | Gut microbiome and metabolic diseases. | 2013 | Details |
| A22963 | 30736139 | Expert Rev Endocrinol Metab | Current management of patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22970 | 24159791 | Klin Med (Mosk) | [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type]. | 2013 | Details |
| A22973 | 24152749 | Nutrients | Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A22977 | 24150574 | Aging Clin Exp Res | Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly. | 2013 | Details |
| A22980 | 24140091 | Metabolism | Irisin in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22982 | 24138963 | Mayo Clin Proc | Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. | 2013 | Details |
| A22987 | 24133663 | Clin Mol Hepatol | Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. | 2013 | Details |
| A22992 | 24131545 | QJM | Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management. | 2013 | Details |
| A22997 | 24127654 | Curr Med Res Opin | Are statins 'IDEAL' for non-alcoholic fatty liver disease? | 2013 | Details |
| A23022 | 24107103 | Liver Int | Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. | 2013 | Details |
| A23026 | 24100261 | Am J Gastroenterol | Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. | 2013 | Details |
| A23045 | 24080776 | Nat Rev Gastroenterol Hepatol | NAFLD, NASH and liver cancer. | 2013 | Details |
| A23054 | 24074715 | Zhonghua Gan Zang Bing Za Zhi | [Non-canonical Wnt signaling contributes to development of non-alcoholic steatohepatitis in a rat model of type 2 diabetes mellitus]. | 2013 | Details |
| A23057 | 28839736 | Frontline Gastroenterol | Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience. | 2013 | Details |
| A23059 | 24073298 | World J Hepatol | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23061 | 24071688 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | [Effect of metformin on the expression of SIRT1 and UCP2 in rat liver of type 2 diabetes mellitus and nonalcoholic fatty liver]. | 2013 | Details |
| A23063 | 24071517 | Mol Cell Endocrinol | Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. | 2013 | Details |
| A23065 | 24069511 | World J Gastrointest Oncol | Primary hepatocellular carcinoma and metabolic syndrome: An update. | 2013 | Details |
| A23100 | 24040875 | Curr Pharm Des | The role of statins in the treatment of type 2 diabetes mellitus: an update. | 2014 | Details |
| A23101 | 24040873 | Curr Pharm Des | The role of oral antidiabetic agents and incretin mimetics in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A23109 | 24035445 | Metabolism | Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels. | 2013 | Details |
| A23111 | 24033459 | Clin Exp Pharmacol Physiol | Fructose, pregnancy and later life impacts. | 2013 | Details |
| A23129 | 24018493 | Ann Hepatol | Primary care practitioners survey of non-alcoholic fatty liver disease. | 2014 | Details |
| A23132 | 24016432 | Zhonghua Liu Xing Bing Xue Za Zhi | [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China]. | 2013 | Details |
| A23133 | 24015600 | Adv Clin Chem | Markers in nonalcoholic steatohepatitis. | 2013 | Details |
| A23135 | 24011648 | Gastroenterol Hepatol | [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. | 2013 | Details |
| A23151 | 24002776 | Hepatology | Extrahepatic complications of nonalcoholic fatty liver disease. | 2014 | Details |
| A23157 | 23997767 | Int J Endocrinol | Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). | 2013 | Details |
| A23158 | 23997501 | J Clin Exp Hepatol | Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults. | 2013 | Details |
| A23165 | 25755498 | J Clin Exp Hepatol | Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study. | 2013 | Details |
| A23169 | 23834053 | Nutr Hosp | Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. | 2013 | Details |
| A23171 | 23985000 | Expert Rev Gastroenterol Hepatol | Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already? | 2013 | Details |
| A23184 | 23978719 | J Hepatol | Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. | 2013 | Details |
| A23195 | 23971751 | Expert Rev Clin Immunol | Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. | 2013 | Details |
| A23197 | 23969900 | Int J Oncol | Non-B, non-C hepatocellular carcinoma (Review). | 2013 | Details |
| A23203 | 23962548 | Clin Gastroenterol Hepatol | Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. | 2013 | Details |